NOAR, Norfolk Arthritis Register

Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, S Manning, D Symmons, M Lunt

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1449-1455; DOI: 10.1136/ard.2005.049775
Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis
A Barton, H Platt, F Salway, D Symmons, E Barrett, M Bukhari, M Lunt, E Zeggini, S Eyre, A Hinks, D Tellam, B Brintnell, W Ollier, J Worthington, A Silman

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 280-284; DOI: 10.1136/ard.2003.008680

Main menu